CTRI Number |
CTRI/2022/10/046558 [Registered on: 17/10/2022] Trial Registered Prospectively |
Last Modified On: |
28/12/2023 |
Post Graduate Thesis |
Yes |
Type of Trial |
Observational |
Type of Study
|
Interpretive observational study |
Study Design |
Other |
Public Title of Study
|
Program evaluation of hemophilia society activities |
Scientific Title of Study
|
Evaluation of support program extended to people with hemophilia: A multicentric mixed qualitative study |
Trial Acronym |
|
Secondary IDs if Any
|
Secondary ID |
Identifier |
NIL |
NIL |
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
Name |
Diksha D Shroff |
Designation |
Ph.D Scholar |
Affiliation |
Melaka Manipal Medical College (Manipal Campus) |
Address |
Department of Pediatrics
Melaka Manipal Medical College
(Manipal Campus)
Manipal Academy Of Higher education, Manipal
Udupi
KARNATAKA
576104
India
Udupi KARNATAKA 576104 India |
Phone |
9035192920 |
Fax |
|
Email |
dikshashroff10@gmail.com |
|
Details of Contact Person Scientific Query
|
Name |
Dr Dinesh M Nayak |
Designation |
Professor and Head |
Affiliation |
Melaka Manipal Medical College (Manipal Campus) |
Address |
Department of Pediatrics
Melaka Manipal Medical College
(Manipal Campus)
Manipal Academy Of Higher education, Manipal
Udupi
KARNATAKA
576104
India
Udupi KARNATAKA 576104 India |
Phone |
9845226437 |
Fax |
|
Email |
dinesh.nayak@manipal.edu |
|
Details of Contact Person Public Query
|
Name |
Dr Sreejith Govindan |
Designation |
Deputy Registrar - Evaluation (Health Sciences), MAHE Associate Professor of Microbiology |
Affiliation |
Melaka Manipal Medical College (Manipal Campus) |
Address |
Melaka Manipal Medical College (Manipal Campus)
Manipal - 576104
Udupi KARNATAKA 576104 India |
Phone |
9980959353 |
Fax |
|
Email |
g.sreejith@manipal.edu |
|
Source of Monetary or Material Support
|
Manipal Academy of Higher Education, Manipal |
|
Primary Sponsor
|
Name |
NIL |
Address |
NIL |
Type of Sponsor |
Other [NIL] |
|
Details of Secondary Sponsor
|
|
Countries of Recruitment
|
India |
Sites of Study
|
No of Sites = 1 |
Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
Dr Sreejith G |
Manipal hemophilia society |
Kasturba hospital,Manipal -Opp to ENT OPD -4th floor,576104 Udupi KARNATAKA |
9980959353
g.sreejith@manipal.edu |
|
Details of Ethics Committee
|
No of Ethics Committees= 1 |
Name of Committee |
Approval Status |
Kasturba Medical college and kasturba Hospital Institutional ethics commitee |
Approved |
|
Regulatory Clearance Status from DCGI
|
|
Health Condition / Problems Studied
|
Health Type |
Condition |
Patients |
(1) ICD-10 Condition: D67||Hereditary factor IX deficiency, (2) ICD-10 Condition: D66||Hereditary factor VIII deficiency, |
|
Intervention / Comparator Agent
|
|
Inclusion Criteria
|
Age From |
13.00 Year(s) |
Age To |
70.00 Year(s) |
Gender |
Both |
Details |
Persons with hemophilia, care givers (Mother, Fathers and close relatives) those associated for more than 2 years with the society, executive members of the chapters with >2 Years of experience as office bearer. |
|
ExclusionCriteria |
Details |
Females who are diagnosed with hemophilia, PwH who are not a member of a chapter, parents who are not living with PwH, non-residents of India. |
|
Method of Generating Random Sequence
|
Not Applicable |
Method of Concealment
|
Not Applicable |
Blinding/Masking
|
Not Applicable |
Primary Outcome
|
Outcome |
TimePoints |
The proposed study aims at exploring the day to day life and the impact of hemophiliacs being a part of the hemophilia society |
16 months |
|
Secondary Outcome
|
Outcome |
TimePoints |
The evidence of the positive impacts made on the life of PwH and their family by the hemophilia society |
12 months |
|
Target Sample Size
|
Total Sample Size="297" Sample Size from India="297"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
Phase of Trial
|
N/A |
Date of First Enrollment (India)
|
24/10/2022 |
Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
Date of First Enrollment (Global) |
Date Missing |
Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
Estimated Duration of Trial
|
Years="3" Months="0" Days="0" |
Recruitment Status of Trial (Global)
Modification(s)
|
Not Applicable |
Recruitment Status of Trial (India) |
Open to Recruitment |
Publication Details
|
NIL |
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
Brief Summary
|
Hemophilia is an X-linked bleeding disorder, caused by an inherited deficiency of clotting factor VIII (hemophilia A) or factor IX (hemophilia B) which leads to spontaneous and posttraumatic bleeds. At present Indian hemophilia (Bleeding disorder) registry has close to 20,000 hemophilia patients all over the country, though we expect the number to swell near 85,000–1,00,000. People with hemophilia (PwH) and their families have diverse requirements and are best served by a multidisciplinary team of healthcare experts delivering coordinated, comprehensive care. Patient support programs are designed and implemented to provide personalized assistance and tailored interventions to improve patient health outcomes. The purpose of the study is to: · Exploring the lived experiences of a PwH · Assessing the impact of the hemophilia society in the day-to-day life of a PwH · To assess the positive impact made by the hemophilia society in a PwH · Exploring the nature of participation of stakeholders in the facilitation of the activities of the hemophilia society Methods: A multi method qualitative approach using in-depth interviews, focus group discussion and appreciative inquiry ,photo voice method(Photovoice is a qualitative, participatory, action-oriented data collection method whereby study participants use cameras to record their real-life experiences) will be conducted. The interview will be audio recorded with prior consent from the participant. |